期刊文献+

生化药物中猪、牛与羊性成分PCR检测的阳性对照品的构建

Construction of Positive Controls for the Determination of Compositions from Bovine,Porcine and Ovine in Biochemical Medicines by PCR
下载PDF
导出
摘要 目的:建立生化药物中的猪、牛与羊性成分PCR检测方法的阳性对照品,用于检测生产原料的动物来源是猪源性、牛源性或羊源性。方法:分别对自行制备的猪、牛及羊源性成分的阳性对照品,进行了DNA提取,并加入猪、牛与羊特异性引物进行扩增。对扩增产物进行酶切及测序验证。结果:猪、牛及羊阳性对照扩增产物片段长度、酶切片段长度均与目标序列长度一致。结论:所构建的猪、牛与羊性成分的阳性对照品可广泛应用于生化药物的种属鉴别中,对生物药物中猪、牛与羊性成分的核酸检测可进行良好的实验室质量控制。 Objective: To develop the positive controls for the determination of compositions derived from bovine, porcine and o- vine in biochemical medicines by PCR to identify the different animal original materials. Methods: DNA was extracted from the self- made positive controls of the compositions from bovine, porcine and ovine tissues, and then was amplified with the specific primers. The amplified products were digested by enzyme, and then the sequence was detected. Results: The length of amplified segments and enzyme-digested segments was the same with that of the target sequence. Conclusion: The developed positive controls for the composi- tions derived from bovine, porcine and ovine can be applied in the identification of biochemical medicines. Promising quality control can be achieved in laboratory for the detection of nucleic acid from bovine, porcine and ovine in biochemical medicines.
出处 《中国药师》 CAS 2015年第9期1445-1447,1468,共4页 China Pharmacist
基金 广东省医学科研基金资助项目(编号:B2014093 A2013158) 广东省科技计划项目(公益研究与能力建设专项 编号:2014A020218011)
关键词 生化药物 猪、牛与羊源性成分 聚合酶链式反应 Biochemical medicine Bovine; porcine and ovine derived materials PCR
  • 相关文献

参考文献13

  • 1刘昊,连春,王长康,陈文炳,邵碧英.猪源性成分的PCR检测技术优化研究[J].中国农学通报,2009,25(18):1-6. 被引量:5
  • 2陈文炳,邵碧英,廖宪彪,江树勋,李寿崧.加工食品中若干动物成分的PCR检测技术应用研究[J].食品科学,2005,26(8):338-342. 被引量:38
  • 3邵碧英,陈文炳,郑腾,江树勋,张志灯,李寿崧.动物产品中牛、羊源性成分多重PCR检测方法的建立[J].畜牧与兽医,2004,36(3):7-9. 被引量:15
  • 4Haibitz I, Kristen T, Bosttes M,et al. DNA sequence of the akeletalmuscles calcium release channel cDNA and verification of the Arg615-Cys mutationy associated with porcine malignant hyperthermia,inNorwegian Landrace pigs[J]. Animal Genetics, 1992, 23:395-402.
  • 5Huang Q,Xu T,Wang GYyet al. Species-specific identification of ru-minant components contaminating industrial crude porcine heparin u-sing real-time fluorescent qualitative and quantitative PCR[ J]. AnalBioanal C/iem,2012,402(4) :1625-1634.
  • 6Concannon SP, Wimberley PB, Woricman WE. A quantitative PCRmethod to quantify ruminant DNA in porcine crude heparin[ J]. AnalBioanal 0em,2011,399(2) :757-762.
  • 7Yoshida T,Nomura T,Shinoda N,cf al. Development of PCR primersfor the detection of porcine DNA in feed using mtATP6 as the targetsequence[ J]. Shokuhin Eiseigaku Zasshi,2009,50(2) :89-92.
  • 8于智勇,丁鸽,丁小余,褚必海,钱亮,顾笋.猪基源的肝素粗品及混淆品的AS-PCR及ARMS分子检测[J].药学学报,2008,43(5):535-541. 被引量:8
  • 9Beyer T ^ Matz M,Brinz D,et al. Composition of OSCS-contaminatedheparin occurring in 2008 in batches on the German market[ J]. EurJ Pharm Sc.,2010,40(4) :297-304.
  • 10Houiste C, Auguste C, Macrez C al. Quantitative PCR and disac-charide profiling to characterize the animal origin of lowmolecular-weight heparins[ J]. Clin Appl Thromb Hemost ^2009,15 (1) :50-58.

二级参考文献31

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部